Dormant therapy
The term “dormant therapy” refers to a new drug or a new biological product which was made the subject of a request for designation in compliance with the Dormant Therapies Act.patent protection and meets an unmet medical need, improves outcomes, or reduces risks compared to an existing treatment.[2]
Many drugs may be abandoned due to their failure to meet a
clinical trials. This disincentive is even more pronounced for treatments for more complex conditions such as Alzheimer’s
, which require more clinical data than conditions which currently have existing treatments.
References
- ^ "S.l3004 - Dormant Therapies Act of 2014". 11 December 2014.
- ^ "Guidance for IndustryFast Track Drug Development Programs" (PDF). Department of Health and Human Services, U. D. Archived from the original (PDF) on 2011-07-08.